SCHEMBL24864685

SCHEMBL24864685

CC(C)(C)CC(C)(C)C(=O)NCC(C)(C)COCC(C)(C)CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24340877 0.82
SCHEMBL22758126 0.77 SMN1; SMN2 (0.39)
SCHEMBL26047845 0.71
SCHEMBL12843875 0.71
SCHEMBL19594799 0.70 LMNA (0.31)
SCHEMBL25130841 0.70 KDM4E (0.43)
SCHEMBL20866434 0.70 MAOA (0.34)
SCHEMBL26259196 0.70
SCHEMBL23959148 0.69
SCHEMBL25064299 0.68 SMN1; SMN2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023281480-A1 CONJUGATES OF CHECKPOINT INHIBITORS WITH IL-2, AND USES THEREOF BRIGHT PEAK THERAPEUTICS AG (CH) 2023-01-12 WO disclosed